• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Joel Harris - HD Medical

Gender
Male

Trophies

  1. 1

    First Message

    Post a message somewhere on the site to receive this.
Top Bottom
Back